Suppr超能文献

曲美他嗪对氧化还原平衡和血管生成的影响:一项体内实验研究。

Effects of trimetazidine on oxidant-antioxidant balance and angiogenesis; an in vivo experimental study.

作者信息

Kayan Fethullah, Savas Hasan Basri

机构信息

Department of Cardiology, Diyarbakır Gazi Yaşargil Training and Research Hospital, Diyarbakır, Turkey.

Faculty of Medicine, Department of Medical Biochemistry, Mardin Artuklu University, Artuklu, Mardin, Turkey.

出版信息

BMC Cardiovasc Disord. 2025 Apr 10;25(1):275. doi: 10.1186/s12872-025-04701-z.

Abstract

BACKGROUND

We evaluated the effects of trimetazidine (TMZ) on the oxidative-antioxidative balance and angiogenesis in an in vivo experimental model. This study aims to evaluate the effects of trimetazidine on angiogenesis through histological analysis and to assess its impact on oxidative-antioxidative balance through biochemical measurements.

METHODS

In this study, Ross 308 breed chicken eggs (n = 40) were used, and embryos were divided into four distinct groups. On the eighth day of incubation, the vascular density of the embryos was examined. Following the assessment of vascular development, 4-5 mL of albumin was collected via syringe to measure oxidative stress markers. Each group consisted of 10 embryos, with a total of 40 embryos used in the study. The groups were organized as follows: Control Group (CG), Bevacizumab Group (BC), Trimetazidine 10⁻⁴ Group, and Trimetazidine 10⁻⁵ Group.

RESULTS

When the total oxidative capacity (TOC) levels were compared among the groups, the bevacizumab group exhibited significantly higher values than the control group (p < 0.05). In oxidative stress index (OSI) measurements, the bevacizumab group also showed significantly higher values compared to the control group (p < 0.05). In contrast, when the total antioxidant capacity (TAC) levels were compared, both the Trimetazidine 10⁻⁴ and Trimetazidine 10⁻⁵ groups demonstrated significantly higher values than the control group (p < 0.05). Regarding angiogenesis scoring, the bevacizumab group exhibited a significant anti-angiogenic effect compared to the control group. However, no statistically significant difference was observed between the Trimetazidine 10⁻⁴ and Trimetazidine 10⁻⁵ groups and the control group (p > 0.05).

CONCLUSION

Trimetazidine demonstrated significant antioxidant activity in an in vivo Chorioallantoic Membrane (CAM) model at both 10⁻⁴ M and 10⁻⁵ M concentrations. However, no positive or negative effects on angiogenesis were detected. We believe that the real-time observation of angiogenesis in our study provided significant value to our research.

摘要

背景

我们在体内实验模型中评估了曲美他嗪(TMZ)对氧化-抗氧化平衡和血管生成的影响。本研究旨在通过组织学分析评估曲美他嗪对血管生成的影响,并通过生化测量评估其对氧化-抗氧化平衡的影响。

方法

在本研究中,使用了罗斯308品种鸡蛋(n = 40),胚胎被分为四个不同的组。在孵化的第八天,检查胚胎的血管密度。在评估血管发育后,通过注射器收集4-5毫升白蛋白以测量氧化应激标志物。每组由10个胚胎组成,本研究共使用40个胚胎。分组如下:对照组(CG)、贝伐单抗组(BC)、曲美他嗪10⁻⁴组和曲美他嗪10⁻⁵组。

结果

当比较各组的总氧化能力(TOC)水平时,贝伐单抗组的值显著高于对照组(p < 0.05)。在氧化应激指数(OSI)测量中,贝伐单抗组的值也显著高于对照组(p < 0.05)。相比之下,当比较总抗氧化能力(TAC)水平时,曲美他嗪10⁻⁴组和曲美他嗪10⁻⁵组的值均显著高于对照组(p < 0.05)。关于血管生成评分,与对照组相比,贝伐单抗组表现出显著的抗血管生成作用。然而,曲美他嗪10⁻⁴组和曲美他嗪10⁻⁵组与对照组之间未观察到统计学上的显著差异(p > 0.05)。

结论

曲美他嗪在体内绒毛尿囊膜(CAM)模型中,在10⁻⁴ M和10⁻⁵ M浓度下均表现出显著的抗氧化活性。然而,未检测到对血管生成的正面或负面影响。我们认为,本研究中对血管生成的实时观察为我们的研究提供了重要价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33b1/11983985/0b5ab2802277/12872_2025_4701_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验